The Pancreas in AIDS

Overview

Journal Gastroenterol Clin North Am

Specialty Gastroenterology

Date 1997 Jun 1

PMID 9187928

Citations 4

Authors

M S Cappell

Affiliations

Soon will be listed here.

Abstract

Although autopsy studies reveal significant pancreatic lesions in about 10% of AIDS patients, pancreatic lesions infrequently produce symptoms and are rarely recognized premortem. Patients with AIDS can develop pancreatic disease from causes not related to AIDS or AIDS-specific lesions. AIDS-specific causes include opportunistic infection, AIDS-associated neoplasia, and medications used to treat complications of AIDS. Pancreatic involvement is usually part of a widely disseminated tumor and rarely produces clinical symptoms.

Citing Articles

Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients.

Marin R, Tit D, Sandulescu O, Streinu-Cercel A, Bungau S Biomedicines. 2021; 9(8).

PMID: 34440191 PMC: 8392338. DOI: 10.3390/biomedicines9080987.

Antimony toxicity.

Sundar S, Chakravarty J Int J Environ Res Public Health. 2011; 7(12):4267-77.

PMID: 21318007 PMC: 3037053. DOI: 10.3390/ijerph7124267.

A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort.

Riedel D, Gebo K, Moore R, Lucas G AIDS Patient Care STDS. 2008; 22(2):113-21.

PMID: 18260802 PMC: 2561218. DOI: 10.1089/apc.2007.0034.

Gastrointestinal manifestations of HIV infection.

Wallace M, Brann O Curr Gastroenterol Rep. 2000; 2(4):283-93.

PMID: 10981025 DOI: 10.1007/s11894-000-0020-1.